A new vaccine against Alzheimer's, developed by the Austrian biotechnology firm Affiris, will soon be tested in six European countries, the company announced Friday.
Some 420 patients will be recruited to take part in clinical trials in Austria, Croatia, Czech Republic, France, Germany and Slovakia.
The vaccine was already tested for safety and tolerability over the past year.
The clinical trials will now test its efficacy, with results expected as early as 2012.
Apr 26, 2010
Alzheimer vaccine to be tested in six European countries
From a report at the link below: